Page last updated: 2024-08-25

adriamycinol and Lymphoma

adriamycinol has been researched along with Lymphoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Balis, F; Cole, DE; Dombi, E; Lai, C; Lucas, N; Melani, C; Roschewski, M; Steinberg, SM; Widemann, BC; Wilson, WH1
Andersen, A; Holte, H; Slørdal, L1

Trials

2 trial(s) available for adriamycinol and Lymphoma

ArticleYear
Doxorubicin pharmacokinetics and toxicity in patients with aggressive lymphoma and hepatic impairment.
    Blood advances, 2023, 02-28, Volume: 7, Issue:4

    Topics: Aged; Bilirubin; Doxorubicin; Humans; Liver Diseases; Lymphoma; Middle Aged; Rituximab

2023
Pharmacokinetics and metabolism of doxorubicin after short-term infusions in lymphoma patients.
    Cancer chemotherapy and pharmacology, 1999, Volume: 44, Issue:5

    Topics: Adult; Aged; Area Under Curve; Biotransformation; Doxorubicin; Female; Humans; Infusions, Intravenous; Leukocytes, Mononuclear; Lymphoma; Male; Middle Aged; Naphthacenes; Time Factors

1999